To this end, we stratified the 78 HCC patients enrolled in the microarray analysis according to higher or lower tumor expression levels of PRG4 or of the other related genes and evaluated the overall survival rate related to each cohort. Here, PRG4 is linked to hepatocellular carcinoma.